John, 62, felt fine until his yearly scan showed a small spot on his kidney. His doctor called it a tumor. His first thought was surgery. But what if he didn’t need it?
He’s not alone. More people are finding out they have tiny kidney tumors during routine scans. These small renal masses (SRMs) are often less than 2 centimeters wide. That’s about the size of a pea.
Most of these tumors grow very slowly. Some never spread. But the old approach was to remove them fast. Surgery carries risks. These include infection, bleeding, and harm to the remaining kidney.
Now experts are rethinking that choice.
Why surgery isn’t always the answer
Kidney cancer sounds scary. But not all tumors behave the same. Some grow so slowly they may never cause harm. This is especially true in older adults.
About 7 in 10 small kidney tumors found by chance are slow-moving. They’re more likely to die with you than kill you.
Yet many patients still get surgery. That’s called overtreatment. It means going through a major procedure that may not add years to life.
But here’s the twist: watching and waiting may be just as safe.
A new way to manage small tumors
Instead of cutting, doctors can now use active surveillance. This means regular scans to track the tumor. If it grows, treatment starts. If not, the patient avoids surgery.
Think of it like monitoring a crack in a sidewalk. If it stays small, you don’t need to repave the whole driveway.
The kidney works like a filter. Each one has millions of tiny units cleaning your blood. Removing part of it can strain the rest. By keeping the kidney intact, patients may stay healthier longer.
Patients stayed healthy without surgery
This study followed 69 patients across five European centers. All were over 50 and had one small tumor under 2 cm. None had symptoms.
They got scans every 6 to 12 months. Doctors looked for growth or changes. Surgery was only advised if the tumor grew fast or the patient wanted it.
After nearly 8 years, 83% still had not had treatment. That’s more than 4 out of 5 people.
Tumor growth triggered treatment in most cases. Only 17% needed surgery. One person developed spread and later died from kidney cancer.
Overall survival was high. At 8 years, 88% were still alive. Cancer-specific death was just under 10%.
This doesn’t mean this treatment is available yet.
What makes some tumors riskier
Not all small tumors are the same. Some are more likely to grow. The study found clues to help tell them apart.
Tumors that doubled in size in less than 12 years were more active. Those growing deeper into the kidney (endophytic) also carried higher risk.
Scoring tools like RENAL and PADUA help doctors judge this. They look at size, location, and shape. A higher score means closer watch.
These tools can guide who should wait and who might need earlier action.
Doctors say less can be more
Experts say this study adds strong proof that active surveillance is safe. It’s not just a backup plan. For many, it should be the first choice.
This approach is already used in prostate cancer. Tiny tumors are tracked for years. Many men never need treatment.
Now kidney care may follow the same path.
What this means for patients
If you’re over 50 and find a small kidney tumor, ask about active surveillance. It may let you avoid surgery and keep your kidney healthier.
Talk to your doctor about your tumor’s size, location, and growth rate. Some people still need surgery. But many can wait safely.
The study had limits
This was a small study with no control group. All patients chose surveillance. Most were older and healthy. Results may not apply to younger or high-risk patients.
Also, it was not a randomized trial. That means we can’t say for sure that surveillance caused the good outcomes. But the long follow-up adds weight to the findings.
More research is on the way
Larger trials are now comparing active surveillance to surgery and other treatments. These will help confirm who benefits most.
For now, this study supports a shift in care. Watching small kidney tumors closely may be the smarter, safer choice for many.
